TITLE

Efficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder

AUTHOR(S)
Bellino, Silvio; Paradiso, Erika; Bogetto, Filippo
PUB. DATE
June 2008
SOURCE
CNS Drugs;2008, Vol. 22 Issue 8, p671
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Borderline personality disorder is a pervasive pattern of instability of inter-personal relationships, affects and self-image, as well as marked impulsivity. Although psychotherapy is needed to attain lasting improvements in a patient's personality and overall functioning, practice guidelines state that pharmacotherapy is indicated to manage state symptoms and trait vulnerabilities. Three psychopathological dimensions are the main targets for pharmacotherapy of borderline personality disorder: affective dysregulation, impulsive-behavioural dyscontrol and cognitive-perceptual symptoms. Guidelines recommend the use of antidepressant agents and mood stabilizers for affective dysregulation and impulsive-behavioural dyscontrol, and antipsychotics for cognitive-perceptual symptoms. This review aims to report and discuss data from clinical trials, reviews and meta-analyses concerning drug efficacy and tolerability in the treatment of borderline personality disorder. Investigations that considered antidepressant agents mainly focused on SSRIs, which are recommended as first-line treatments for affective instability and impulse dyscontrol. Both open-label and randomized controlled studies have been performed, predominantly concerning the efficacy of fluoxetine and fluvoxamine. Other classes of antidepressants, such as TCAs and MAOIs, were investigated as alternative treatments for borderline personality disorder, but the risk of adverse effects and toxicity is a limitation to their use in clinical practice. Increasing amounts of data have recently been collected on the use of mood stabilizers to control mood instability and impulsivity in patients with borderline personality disorder. More substantial data were derived from controlled trials of valproate semisodium, although other drugs such as lithium, carbamazepine, oxcarbazepine and lamotrigine were tested with promising results. Several first-generation antipsychotics were studied in open-label and controlled trials, with good effects on behavioural dyscontrol and psychotic-like symptoms. Selection biases and heterogeneity of drugs and methods somewhat limited the value of these results. More recent investigations have examined atypical antipsychotics, with most of these studies being open-label trials with small sample sizes; however, a few controlled studies have been performed using olanzapine, showing improvements in impulsivity, anger and hostility. In conclusion, a large number of different drugs have been evaluated in the treatment of patients with borderline personality disorder. Initial findings are encouraging for many of these drugs. However, data need to be replicated in further controlled studies with head-to-head comparisons and long-term followups. Many questions remain to be answered.
ACCESSION #
35282116

 

Related Articles

  • A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Young, J.P.R; Hughes, W.C.; Lader, M.H. // British Medical Journal;5/8/1976, Vol. 1 Issue 6018, p1116 

    Investigates the amitriptyline or flupenthixol treatment on depressed patients under double-blind procedures. Consideration on the treatment procedures; Developments on patients after treatments; Absence of distinct characteristics of drug effectivity.

  • AUGMENTATION OF ANTIDEPRESSANTS WITH BRIGHT LIGHT THERAPY IN PATIENTS WITH COMORBID DEPRESSION AND BORDERLINE PERSONALITY DISORDER.  // Biomedical Papers of the Medical Faculty of Palacky University i;2010, Vol. 154 Issue 4, p355 

    No abstract available.

  • Letters to the Editor. Abbass, Allan; Kennedy, Sidney H; Segal, Zindel V; Lam, Raymond W; Whitney, Diane K; Swenson, J Robert; Bradwejn, J; Ungar, Thomas E; Benazzi, Franco; McFarthing, AM; Iacovides, A; Fountoulakis, KN; Fotiou, F; Fokas, K; Nimatoudis, I; Kaprinis, G; Coupland, Nick J // Canadian Journal of Psychiatry;Mar2002, Vol. 47 Issue 2, p193 

    Reports issues related to psychiatry in Canada. Development of short-term psychotherapies in the treatment of depression; Promotion of shared mental health care; Etiology of borderline personality disorder.

  • Depression and borderline personality disorder. Beatson, Josephine A; Rao, Sathya // Medical Journal of Australia;Oct2013 Supplement S8, Vol. 199, pS24 

    Summary: Borderline personality disorder (BPD) is a serious mental illness characterised by dysregulation of emotions and impulses, an unstable sense of self, and difficulties in interpersonal relationships, often accompanied by suicidal and self‐harming behaviour.Major depressive disorder...

  • Depression and borderline personality disorder. Lacey, Darryl L.; Beatson, Josephine A.; Rao, Sathya // Medical Journal of Australia;12/3/2012, Vol. 197 Issue 11/12, p620 

    A letter to the editor is presented in response to the article "Depression and Borderline Personality Disorder," by J. A. Beatson and S. Rao in the 2012 volume 1 "MJA Open" Supplement 4.

  • The Depressive Impulse-ridden Character and the Core Borderline Personality. Goldstein, William N. // American Journal of Psychotherapy;Jan1988, Vol. 42 Issue 1, p28 

    Discusses the differences between depressive impulse-ridden character and the more pathological core borderline personality. Origins of the term borderline personality; Ego-psychological diagnostic approach; Borderline personality in accordance with O. Kernberg.

  • Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy. Bellino, Silvio; Zizza, Monica; Rinaldi, Camilla; Bogetto, Filippo // Canadian Journal of Psychiatry;Nov2007, Vol. 52 Issue 11, p718 

    Objective: The combination of antidepressants and brief psychotherapies has been proven more efficacious in treating major depression and is particularly recommended in patients with concomitant personality disorders. We compare the effects of 2 combined therapies, fluoxetine and...

  • Dissociation in BPD may relate to self-mutilation.  // Psychotherapy Letter;Dec94, Vol. 6 Issue 12, p7 

    Cites a study stating that female patients with borderline personality disorder (BPD) who experience dissociation may be at high risk for depression, self-mutilation and utilization of psychiatric treatment. Study procedure; Levels of current depressive symptomatology and past psychiatric...

  • Autobiographical Memory in Borderline Personality Disorder and Depression1. Renneberg, Babette; Theobald, Erika; Nobs, Monika; Weisbrod, Matthias // Cognitive Therapy & Research;Jun2005, Vol. 29 Issue 3, p343 

    Responses to an autobiographical memory test (AMT, Williams & Broadbent, 1986) are examined in a sample of 30 female psychiatric inpatients with borderline personality disorder (BPD) in comparison to a group of 27 depressed inpatients and a nonclinical control group of 30 women. Concordant with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics